Business case for Trams to Newhaven ‘remains on track’

An update to the final business case for the Trams to Newhaven project, which reflects the impact of the ongoing COVID-19 pandemic, concludes that the economic case for the scheme remains positive.

The review aims to assess the impact any changes in public transport demand as a result of the crisis could have on the economic and financial case, first approved in March 2019. On Thursday (12 November 2020) members of the Transport and Environment Committee will be asked to consider the updated final business case (FBC) and to approve continuing with the construction of the project.

The Council’s economic advisers, have developed a series of possible scenarios to stress-test the findings in the original FBC. These range from a return to business as usual to a permanent reduction in demand, taking into account short-term COVID-19 impacts and views on future growth. In each of the scenarios, modelling suggests that the economic case for the project remains, with a benefit-to-cost ratio of above one.

Financial assessment has found that the project can still be delivered within the budgeted £207.3m and that, in all but one of the scenarios, the impact on Council reserves if the project is cancelled would be greater than continuing construction. While it is possible there could be a future call on Council reserves to support financing costs as a result of COVID-19, in each scenario the scheme will finance itself, albeit in different timeframes.

The refreshed FBC also highlights that the completion will play a key role in the future growth and development of the city. Delivering the tram line to Leith will unlock a large area of the city for housing and economic development, while providing a low-carbon, clean mode of transport to densely populated communities.

Transport and Environment Convener Councillor Lesley Macinnes said: “It’s clear that the events of this year have had an unprecedented impact on the way we travel and that we’ll continue to feel the effects for the foreseeable future. In light of this, it’s essential that we assess the potential economic and financial impacts on such a significant transport infrastructure scheme.

“I’m pleased that the economic and financial cases for Trams to Newhaven hold up despite the ongoing pressures resulting from COVID-19. The delivery of this project is essential for the Capital’s green recovery, providing sustainable, low-carbon travel to one of the city’s most densely populated areas. We now have reason to be cautiously optimistic as we progress with construction.”

Transport and Environment Vice Convener Councillor Karen Doran said: “The Trams to Newhaven project is exactly the kind of investment we need post-COVID-19 to ensure Edinburgh is a thriving, forward-looking place for people to live and work in and to deliver much needed housing, jobs and investment into north Edinburgh.”

Work on the Trams to Newhaven project was instructed to stop on 25 March following guidance from the First Minister on COVID-19 and recommenced in June. While the site shutdown incurred costs, these have been covered by the overall budget and delays have been mitigated.

An updated programme shows that the project is still working towards Spring 2023 for completion and is forecast to be delivered within the agreed budget.

Over recent months, Edinburgh has experienced a significant drop in demand for public transport, with long-term consequences expected including a decline in income to the tram service.

The review of the FBC takes this into account, with even the most optimistic of scenarios projecting that passenger numbers won’t return to pre-COVID levels until the mid-2020s. Finally, the review of the FBC acknowledges the impact of COVID 19 on Lothian Buses and does not rely on any further payment of the extraordinary dividend which was anticipated in the original FBC.

Since March 2019 several local and national strategies have emerged to further support the introduction of high capacity, high quality public transport in the city. While Scotland’s National Transport Strategy 2 (NTS2) envisions ‘sustainable, inclusive, safe and accessible transport’, Edinburgh’s draft City Mobility Plan strives for a greener, safer and connected transport system.

The tram will support the delivery of transport policies such as City Centre Transformation, which proposes a series of interventions to provide a more liveable, people-friendly city centre and requires a mode shift to public transport to help deliver a 10-15% reduction in city centre car traffic in the medium term and a 25-30% reduction in the longer term.

Read the full report, Trams to Newhaven – COVID-19 Final Business Case Refresh, online. 

Watch Transport and Environment Committee live via webcast from 10am on Thursday, 12 November.

While the city council pushes ahead with the trams project, the Inquiry into the Edinburgh Tram project also continues – albeit at a snail’s pace.

The inquiry aims to establish why the original Edinburgh Tram project incurred delays, cost more than originally budgeted and through reductions in scope delivered significantly less than projected.

The inquiry, under Lord Hardie, was set up in June 2014 but is yet to report any findings.

Back in June a spokesperson for the Edinburgh Tram Inquiry told the BBC: “The findings of the inquiry into why the Edinburgh Trams project incurred delays, cost more than originally budgeted and delivered significantly less than planned will be made available at the earliest opportunity.

“Lord Hardie’s remit is to conduct a robust inquiry and it will take as long as is necessary to get the answers required to fulfil the terms of reference.

“We continue to make good progress, including managing more than three million documents on the inquiry’s evidence database for handover to National Records of Scotland.

“A relevant set is also being prepared to be made available on the inquiry’s website to accompany the published report at the appropriate time.”

A scathing review by Audit Scotland in February 2011 noted the original tram project had been undermined by poor planning, cost underestimates, contract disputes and a lack of clear leadership by the council – a lengthy catalogue of calamities which has cost taxpayers £ millions.

Little Dobbies opens in Edinburgh

Dobbies’ first small format store, Little Dobbies, opened its doors for the first time yesterday.

Located on Raeburn Place, Little Dobbies offers a range of houseplants and gardening products. This is complemented by a carefully curated range featuring indoor and outdoor pots; a selected range of home décor and gifts; and seasonal ranges.

There’s also coffee shop, offering hot and cold drinks, as well as tasty takeaway sweet treats. 

Little Dobbies is open Monday-Friday (10:00-18:00), Thursday (10:00-19:00) and Saturday and Sunday (09:00-18:00). 

For further information visit Dobbies.com

PICTURES: Stewart Attwood Photography

Better outcomes for stroke patients in Scotland

The first step towards a national thrombectomy service for stroke patients is underway with the launch of a pilot in the North of Scotland.

Thrombectomy is a highly skilled procedure in which blood clots are removed mechanically rather than broken down by medicines (thrombolysis). It is used to treat those with severe stroke and reduce their risk of long-term disability.

NHS Tayside developed a training programme in Mechanical Thrombectomy (MT), supported by the Scottish Government. Key staff were trained by Professor Iris Grunwald, one of the UK’s leading stroke thrombectomy interventional neuroradiologists, using advanced simulation techniques.

Initially the thrombectomy procedures in Dundee will be performed on patients in Tayside before the service is extended to patients across the North.

A fully operational 24/7 service is anticipated in Tayside by 2023, and will form part of a national network in line with the Scottish Government’s Programme for Government commitment.

In the West of Scotland, the Queen Elizabeth University Hospital campus will provide a ‘hub’ thrombectomy service for the West of Scotland by 2023, while the NHS Lothian service will also be operating from the Little France site within the same timeframe.

Health Secretary Jeane Freeman said: “Over the past 10 years, the number of people dying from stroke in Scotland has decreased by more than 35%. While this is significant progress, we can still achieve even better outcomes.

“A quality and clinically safe thrombectomy service is part of our wider commitment in this year’s Programme for Government to ensure those who experience severe stroke receive the best possible treatment and care.

“It is testament to our healthcare professions that we are now seeing this first step towards a national roll-out, despite the additional pressures placed on them during the pandemic and I want to thank them for their hard work.

“Funding will continue to be made available to other boards to develop the programme and the framework.”

Honorary consultant interventional radiologist in NHS Tayside Professor Graeme Houston said: “We are delighted to be able to launch this service to provide mechanical thrombectomy for patients in the North of Scotland.

“Thrombectomy delivers a significant benefit for some patients who have sudden onset of stroke with significantly improved outcomes and a reduced level of disability.”

Chest Heart & Stroke Scotland Chief Executive Jane-Claire Judson said: “It’s good that we are seeing tangible progress towards thrombectomies being available to stroke patients in Scotland. 

“People in Scotland must be given the best possible chance of living without disability or dependency after a stroke.  We know that at least 600 people a year in Scotland would benefit from a thrombectomy. Developing the skills to deliver this procedure is a key part of establishing the service in Scotland.

“This progress is being driven by inspirational stroke survivors campaigning for change.  Together, we will keep campaigning to make sure that this game-changing stroke treatment is available as soon as possible.”

The Stroke Association in Scotland welcomes the announcement that mechanical thrombectomy is to be made available to some Scots for the first time since 2018.

This is a long overdue but a significant first step towards delivery of a national thrombectomy service for the whole of Scotland which should be in place by 2023.

Thrombectomy is vital. Around 700 stroke patients are eligible for the procedure in Scotland each year. Patients who have a stroke caused by a large blood clot in the brain would potentially benefit from a thrombectomy procedure.

It involves inserting a catheter into an artery, usually within six hours of someone having their stroke, to remove the blood clot. This allows blood flow to resume and oxygen to reach brain tissue.

The treatment can dramatically reduce the devastating consequences of stroke such as losing the ability to walk and talk. Around one in three people who receive a thrombectomy after their stroke will be less disabled as a result, and around one in five of those who receive it will be able to function completely independently afterwards.

Andrea Cail, Director Scotland for the Stroke Association said: “Thrombectomy is a game-changing treatment, and it is good to finally have it available in Scotland again. But it is only the first step. Stroke is now a clinical priority in Scotland and restarting a thrombectomy service for those need it will be the difference between living or dying; living permanently disabled or without any disabilities at all.

“Thrombectomy is an extraordinary, highly-specialised, procedure that can save lives, reduce disability and is absolutely cost effective. One thrombectomy patient is estimated to save the NHS £47,000 over a five year period.

“We congratulate everyone involved in the North of Scotland thrombectomy planning group on making this happen. We know it’s not been easy. It has required serious commitment from everyone involved. By working together, hundreds of people affected by stroke and their families will benefit over the next few years.

“All Scots deserve the same. Thrombectomy must also be made available to the larger population centres of Glasgow and Edinburgh as soon as possible.

“We urge all those involved in developments for these next two sites to work together with purpose, and for the Scottish Government and Health Boards involved to urgently resolve or remove any barriers towards implementation and delivery.  The time it has taken and is taking Health Boards to sort this out is lengthy and unacceptable.”

Professor Rustam Al-Shahi Salman, consultant neurologist in Edinburgh and President of the British Association of Stroke Physicians, says: “Mechanical thrombectomy for acute ischaemic stroke is one of the most effective treatments in modern medicine.

“We knew this in 2015. In the last five years, about 45 people in Scotland have had this treatment, but about 700 people should have it each year. I am relieved that this dire disservice to patients with stroke is beginning to come to an end in Tayside. Patients elsewhere in Scotland deserve the same.”

Case study

Norrie Andrews, 77, from Glasgow had his stroke in Majorca last year.  Only a few days into the holiday, Anne, Norrie’s partner, had gone to check on some electricity issues they had been experiencing.  On her return, she found Norrie slumped over the side of his chair unable to talk and unable to move.  Norrie had had a massive stroke. 

He was taken to the local hospital quickly, and was administered with thrombolysis, a drug to break up the clot.  Unfortunately the thrombolysis had no effect and the doctors decided Norrie would benefit from thrombectomy. He was immediately transferred to Son Espases University Hospital in Palma.

 Anne had to give consent for Norrie to undergo thrombectomy (on his behalf.)  It felt like an endless series of questions and forms that needed answered. 

The procedure took 15 minutes and when Anne went up to the intensive care unit to see him she was amazed.  He was alert, his speech was starting to come back and some movement too. They could hardly believe how something so horrifying had turned on its head.

Norrie still had some mild impairments, but the seriousness of his disability was saved (they believe,) by thrombectomy.  And just over two weeks later, Norrie walked out of hospital without any difficulty and his speech was fine. 

Anne said: “The doctors told me that had Norrie not had thrombectomy, he would never have been out of a wheelchair or spoken again. I was so relieved to hear this and we both felt very fortunate to have been in Majorca at the time.

“After returning home, I discovered thrombectomy would not have been available at the time of Norrie’s stroke. I was amazed to think a small island like Majorca had the treatment my husband so badly needed. Norrie is now back to his old life again. 

“He walks every day and I am thrilled he has started to play golf again. He keeps his brain ticking over with puzzles, crosswords and word searches.  He’s seeing his friends now, which has lifted his spirits and I’m able to see my own friends too.

“I am thrilled to hear thrombectomy is available in Scotland now.  Stroke is a devastating illness and the disability caused by a stroke can be lifelong, destroying lives. I hope now there will be more people in Scotland making better recoveries from stroke because of thrombectomy.”

Boris Johnson: ‘Tonight, that toot of the bugle is louder’

Prime Minister’s statement on coronavirus (COVID-19): 9 November 2020

Across the country and around the world this evening, people are asking one question about our fight against Covid. Does the news of progress towards a vaccine that’s been announced today mean we are at the beginning of the end of our troubles?

So, let me set out our assessment.

The Pfizer/BioNTech Vaccine has been tested on over 40,000 volunteers and interim results suggest it is proving 90 per cent effective at protecting people against the virus.

But we haven’t yet seen the full safety data, and these findings also need to be peer-reviewed.

So we have cleared one significant hurdle but there are several more to go before we know the vaccine can be used.

What I can say is that if and when this vaccine is approved, we, in this country, will be ready to start using it.

Earlier this year the UK Government ordered 40 million doses of the Pfizer vaccine – enough for about a third of the population, since you need two doses each.

That puts us towards the front of the international pack on a per capita basis – and I should add we’ve ordered over 300 million doses from 5 other vaccine candidates as well.

If the Pfizer vaccine passes all the rigorous safety checks and is proved to be effective then we will begin a UK-wide NHS led programme of vaccine distribution.

We will decide the order in which people are offered the vaccination taking account of recommendations from a group of scientific experts, the Joint Committee on Vaccination and Immunisation.

They’re looking at a range of factors, including the different characteristics of different types of vaccines, to work out the most effective way to protect as many people as possible and save as many lives as we can.

And we will be setting out more detail about that in due course.

But – and you know I am going to say this – I must stress, these are very, very early days.

We have talked for a long time, or I have, about the distant bugle of the scientific cavalry coming over the brow of the hill. And tonight that toot of the bugle is louder. But it is still some way off.

And we absolutely cannot rely on this as a solution.

The biggest mistake we could make now would be to slacken our resolve at such a critical moment.

On Friday, SAGE reported that the R is above 1 in England – though this does not take into account the current national restrictions.

Alas, the death figures are tragically rising, running at an average of over 300 a day – sadly double where they were 24 days ago

The number of Covid patients in hospital has risen from just over 10,000 two weeks ago to nearly 13,000 on 5 November, and we are heading towards the levels of the previous peak.

Irrespective of whether there is a vaccine on the way or not we must continue to do everything possible right now to bring the R down. And that is why we hope and believe that mass testing will help.

Our first pilot began in Liverpool on Friday, in partnership with Liverpool City Council.

We’ve tested thousands of people there but there are still a lot more to do, so please if you are in Liverpool, get yourself along to a testing centre – there are 19 at the moment with more still to come.

The more people get tested the better we can protect that great city, and drive the disease down in Liverpool so do it for your friends, for your relatives, for your community.

And I want to thank the fantastic support of the army, the people of Liverpool and Liverpool City Council.

And we are now going further by sending out hundreds of thousands of rapid lateral flow tests to local authorities right across England – and also of course to the Devolved Administrations.

We’re also working with universities to establish, as soon as possible, similar mass testing capacity for students up and down the country.

But while we are making progress this project is still in its infancy.

And neither mass testing nor progress on vaccines –both vital arrows in our epidemiological quiver, both key parts of our fight against Covid – are at the present time a substitute for the national restrictions, for social distancing, for hand hygiene and all the rest.

So it is all the more important to follow the rules.

I know it’s been a tough first weekend of these Autumn restrictions and I’m especially grateful to the Royal British Legion and all those who worked so hard to ensure that no virus would stop us yesterday from honouring the memory of those who gave their lives for our freedom.

But we must get through this to 2nd December, when these measures expire and we plan to move forward with a tiered approach.

Remember the basics, hands, face, space, and the follow the rules: that is how we can together protect our NHS, save lives and get this virus back in its box.

And that is what we will do.

So thank you.

Social media giants agree package of measures with UK Government to tackle vaccine disinformation

  • Platforms endorse the principle that no company should be profiting from COVID-19 vaccine mis/disinformation and commit to swifter responses to flagged content
  • Platforms will step up work with public health bodies to promote factual and reliable messages

Digital Secretary Oliver Dowden and Health Secretary Matt Hancock have agreed with social media platforms new measures to limit the spread of vaccine misinformation and disinformation and help people find the information they need about any COVID-19 vaccine.

At a virtual roundtable to address the growth of vaccine disinformation, Facebook, Twitter and Google committed to the principle that no company should profit from or promote COVID-19 anti-vaccine disinformation, to respond to flagged content more swiftly, and to work with authorities to promote scientifically accurate messages.

As the UK moves closer to developing a safe and effective COVID-19 vaccine, Mr Dowden and Mr Hancock used the roundtable to welcome the progress these companies have made in strengthening their policies towards false coronavirus information and helping publicise the steps people should take to prevent the spread of the virus.

But the ministers raised concerns about the length of time misleading and false information about coronavirus vaccines remains on platforms, and called for swifter action to tackle such content.

Together the platforms have now agreed:

  • To commit to the principle that no user or company should directly profit profit from COVID-19 vaccine mis/disinformation. This removes an incentive for this type of content to be promoted, produced and be circulated.
  • To ensure a timely response to mis/disinformation content flagged to them by the government.
  • To continue to work with public health bodies to ensure that authoritative messages about vaccine safety reach as many people as possible.
  • To join new policy forums over the coming months to improve responses to mis/disinformation and to prepare for future threats.

The forums will see the government, social media platforms, public health bodies and academia increase their cooperation and ongoing information sharing to deliver a better understanding of the evolving threat caused by false COVID-19 vaccine narratives.

Digital Secretary Oliver Dowden said: “Covid disinformation is dangerous and could cost lives. While social media companies are taking steps to stop it spreading on their platforms there is much more that can be done.

“So I welcome this new commitment from social media giants not to profit from or promote flagged anti-vax content, given that making money from this dangerous content would be wrong.”

Health Secretary Matt Hancock said: “After clean water, vaccination is the most effective public health intervention in the world and has saved countless lives across the globe, eradicating one disease entirely.

“I am encouraged that social media companies have agreed to do more to prevent the spread of dangerous misinformation and disinformation on their platforms.

“We want users to have greater access to reliable and scientifically-accurate information on vaccines from trusted sources like the NHS so they can make informed decisions to protect themselves and their loved ones.”

Vaccines are overwhelmingly safe and effective healthcare solutions. Ministers used the meeting, which also included representatives from fact-checking charities, academics and data experts, to highlight that robust action must be taken against misleading messaging and content online which could harm and discourage people from protecting themselves or their loved ones.

Throughout the pandemic the government’s Counter Disinformation Unit has been developing a picture of the extent, scope and reach of disinformation and working with online platforms to ensure appropriate action is taken.

The unit has observed a range of false narratives about coronavirus vaccines across multiple platforms, including widespread misuse of scientific findings and baseless claims challenging the safety of vaccines or plans for their deployment.

Ronan Harris, Google UK Managing Director, said: “Since the beginning of the covid-19 epidemic, we have worked relentlessly to promote authoritative content from the NHS and to fight misinformation.

“In the last few months, we have continued to update our policies to make sure that content contradicting scientific consensus about the virus is swiftly removed and demonetised.

“Today, we are redoubling our commitment to take effective action against covid vaccine misinformation and to continue to work with partners across Government and industry to make sure people in the UK have easy access to helpful and accurate Information.”

Katy Minshall, Head of UK Public Policy, Twitter UK, said: “We are focused on protecting the public conversation and helping people find authoritative information on Twitter – in May 2019, we launched a search prompt that serves people with credible vaccine information from the NHS.

“In January this year, we launched a dedicated COVID-19 search prompt, ensuring that when people come to the service for information, they’re met with authoritative, public health information first. To date, over 160 million people have visited the Twitter COVID-19 curated page, over two billion times.

Since introducing COVID misinformation policies in March, and as we’ve doubled down on tech, our automated systems have challenged millions of accounts which were targeting discussions around COVID-19 with spammy or manipulative behaviours.

“We remain committed to combating misinformation about COVID-19, and continue to take action on accounts that violate our Rules. We look forward to continued collaboration with government and industry partners in our work towards improving the health of the public conversation.

Rebecca Stimson, Facebook’s Head of UK Public Policy, said: “We’re working closely with governments and health authorities to stop harmful misinformation from spreading on our platforms.

“Ads that include vaccine hoaxes or discourage people from getting a vaccine are banned, we remove harmful misinformation about Covid-19 and put warning labels over posts marked as false by third party fact checkers.

“We’re also connecting people to accurate information about vaccines and Covid-19 whenever they search for these topics. In the first months of the pandemic we directed more than 3.5 million visits to official advice from the NHS and UK government and we’re pleased to continue to support public health efforts.”

Tribute to former Scotmid employee and Director, John (Ian) Miller

Harry Cairney, Scotmid President and John Brodie, Chief Executive paid tribute to former employee and Director, John (Ian) Miller.

It is with deep sadness that we pay tribute to the passing of John (Ian) Miller, former employee, Director and East Regional Committee member.  John passed away suddenly, aged 72.

Known as John to his friends and colleagues at Scotmid, he served the Society both as an employee and as a democratically elected member.  He was Manager at our Penicuik non-food branch for 15 years before starting his own carpet business and went on to serve on the democratic side of the Society, representing Members in our East Region for 17 years and then the Board for 9 years. 

It is very sad that John passed away so soon after retiring from our Board and East Regional Committee at the Society’s AGM in September. 

John was widely known and respected within the co-operative movement and in his local community.   It is difficult to quantify the contribution which he made both to Scotmid and the cooperative movement over many years. 

He represented the Society on a wide range of Boards and Committees over the years and was a fouder member of Fairtrade Midlothian.  He was a true gentlemen with a firm belief in co-operation and the benefits of the co-operative movement and would champion these at every occasion.

John will be sorely missed by all at Scotmid and our thoughts are with John’s family and friends at this very sad time.

2,500 Scottish children seek help from Childline over mental health since lockdown began

  • Young people share that they don’t fit in or feel ‘normal’
  • Childline launches Nobody is Normal campaign to let children know they aren’t alone

Since lockdown measures were first introduced Childline has delivered almost 2,500 counselling sessions with children in Scotland about mental and emotional health issues including loneliness and low self-esteem.

Childline’s volunteer counsellors have heard from many children who, after being cut off from important support networks, shared that they were feeling isolated, anxious and insecure.

Now, with stricter social-distancing measures imposed again across the UK, Childline is launching a new campaign called Nobody is Normal. It aims to help children understand that lacking confidence, feeling not good enough or that you don’t fit in, is a shared experience. Childline is encouraging them not to suffer in silence. 

Developed with young people, the campaign features a bold new animation of a young boy who is struggling with anxiety while desperately trying to appear ‘normal’. Backed by Radiohead’s hit song Creep, it reminds young people that no matter how isolated they feel, they are not alone and Childline is here.

Childline delivered higher monthly numbers of counselling sessions with children in Scotland about a range of mental health-related issues in April, May and June, including low self-esteem, loneliness and worries about the world. Mental health remains the top reason young people get in touch with Childline, making up over a third of all counselling sessions delivered in the UK.

In the last seven months, Childline has delivered nearly 43,000 counselling sessions about mental and emotional health with children across the UK.

The NSPCC, which runs Childline, can also reveal that the number of UK contacts about body image, gender and sexuality increased since the end of March.

Since lockdown measures were first introduced, the monthly average number of Childline counselling sessions across the UK about eating and body image disorders increased by almost a third (32%) on the pre-lockdown average. Similarly, the monthly average number of sessions about sexuality and gender identity increased by 16% compared with the pre-lockdown average.

Counsellors have heard that some children have developed unhealthy eating behaviours for the first time such as binge eating and bulimia nervosa, and those with existing eating disorders have experienced worsened symptoms, or a relapse.

While the service has heard that lockdown gave some LGBTQ+ children the confidence to come out to their friends and family, others expressed fears about coming out and some young people were left unable to cope after receiving a negative response.

A 14-year-old child told Childline: “I think I’m transgender and I have no one to talk to. I have always been a tomboy and never fitted in with the girls. I was fine with it for a while, but recently I have become very uncomfortable with my gender and I’m really struggling. I feel stuck, I wish someone can help me.”

A young girl told Childline: “I don’t know if it’s just me being sad because of lockdown, but I’ve been feeling really disgusting in my own body lately. All my friends have clear and beautiful skin with even tones, but mine is spotty and red and covered in freckles. I just feel like I’m always the odd one out”

Throughout the pandemic, Childline counsellors have heard from children who have shared that the crisis has affected their mental and emotional health.

Childline Founder, Dame Esther Rantzen said: “The pandemic has cut children off from the reassurance many of them need. When young people are facing mental health issues such as anxiety or depression or are struggling with eating disorders or self-harm, they often hide it from their parents and families.

“A lockdown intensifies stress in all our lives, and the Childline team know from past experience that it has made many children feel especially isolated. 

“The Nobody is Normal campaign encourages any children feeling unable to discuss their anxiety and distress to reach out to Childline for support. Many young people are under immense pressure from social media to look and behave like everyone else, but the campaign recognises that we are all individuals, special and unique.

“If these tough times have caused children to feel an extra level of anxiety, we want them to feel confident to express their fears and share their worries, and know that Childline is still here for them.”

Airlines ignoring EU guidance on voucher refunds

British Airways and EasyJet are going against EU guidance and refusing to refund unused vouchers for flights cancelled during the pandemic, Which? can reveal.

Some passengers willingly accepted vouchers in place of cash refunds when their flights were cancelled because of coronavirus, believing they were helping the airlines. But others claim they weren’t told they were entitled to cash refunds, or that they were misled into accepting vouchers they didn’t want.

The European Commission issued guidance in May recommending that airlines automatically refund any unused vouchers 14 days after they expire. However, this is only guidance, not a legal requirement.

While Ryanair says its vouchers can be refunded at any time, BA and Easyjet insist that once issued, their vouchers can not be exchanged for cash. That means passengers could be left hundreds of pounds out of pocket if they do not use them by the time they expire.

When flights are cancelled by an EU airline or by an airline flying from an EU airport, passengers are entitled to a cash refund under EU Regulation 261 within seven days of the cancellation. But after the pandemic grounded most flights leaving the UK earlier this year, all of the UK’s biggest airlines failed to meet this legal requirement, and many passengers were given vouchers instead.

At the height of the pandemic earlier in the year, many customers with cancelled flights struggled to contact airlines to ask for their money back. BA customers in particular complained after the airline removed its online refund form from its website and directed people to its overwhelmed customer service line, which played an automated message before hanging up on the passenger.

Some BA passengers have also complained to Which? that they automatically received vouchers for cancelled flights when they thought they’d applied for refunds through the website’s ‘Manage my booking’ page.

Jackie Harbridge says when she called BA to request a refund a recorded message directed her to Manage My Booking on BA’s website, but when she clicked on the refund button, she says she received a voucher for £2,118 for the flights to San Francisco.

She tried to call BA immediately, but struggled to get through. When she eventually got to speak to an agent she was told that since she had requested vouchers the decision could not be reversed.

“I was completely misguided by the instruction in BA’s Manage My Booking, which specifically quoted ‘Refund’ but turned out to be for a voucher, which is completely useless to us,” said Jackie. She and her 83-year-old husband no longer plan to travel so they can’t make use of the vouchers.

BA denies its claims process is misleading, saying that it has issued more than 2.1 million cash refunds. It said it is clear that customers must call to request cash refunds, and insists that they only get a voucher if they fill out a form that clearly states they are requesting a voucher.

While Easyjet passengers can request a refund online when their flight is cancelled, some willingly accepted vouchers to help support the airline.

But some passengers now may not be able to use their vouchers because the airline has cut back on some routes in recent months, and Easyjet has said it will only refund vouchers in “exceptional circumstances as a gesture of goodwill”.

An Easyjet spokesperson said: “For passengers who have chosen a voucher as compensation for their cancelled flight, we would only reverse this and offer a refund in exceptional circumstances as a gesture of goodwill if the customer’s circumstances justify it (eg. A school group no longer able to re-travel).”

A number of Easyjet’s flight routes have yet to restart, and a number of routes passengers were initially booked on have been dropped since vouchers were issued, after the airline pulled out of Southend Airport and dropped a number of routes from Newcastle and Stansted airports. Easyjet’s vouchers are only valid for a year, meaning many passengers may be left with vouchers they cannot use.

BA has dropped 60 per cent of its flights up to the end of this year and also pulled out of the Isle of Man. However, it has extended the validity of its vouchers so they can be used any time up to April 2022.

Additionally, BA and Easyjet both say vouchers are transferable, so passengers can pass them on to family and friends if they are unable to use them.

On top of ignoring guidance on refunds for unused vouchers, BA and EasyJet have also said that they will not be offering refunds for flights that operate as scheduled, meaning many passengers will only have the option of rebooking their flight to a later date if they cannot fly due to England’s latest lockdown. Ryanair has also said it will not offer refunds for flights that are not cancelled while passengers are in lockdown.

Which? believes the Civil Aviation Authority should be doing a better job of making it clear to airlines that they should be following legal guidance on vouchers and refunds, but without powers to issue fines or take swift action, it has struggled to get a grip as airlines have played fast and loose with the rules during the pandemic.

To help restore trust in the travel industry, the government must urgently review the CAA’s powers as part of its aviation recovery plan, to ensure passengers have an aviation regulator with the powers it needs to stand up for their rights.

Rory Boland, Editor of Which? Travel, said: “As we head into a winter that is bound to bring more flight cancellations, it’s extremely concerning to see the UK’s biggest airlines disregarding European guidance and letting their passengers down when it comes to their refund rights.

“BA and Easyjet must immediately make it clear that passengers will not face losing their money if they are unable to use a voucher, while all airlines should be offering cash refunds to passengers prevented from travelling by lockdown laws.

“Major airlines have acted shamefully and without fear of consequences during this pandemic – the government must urgently review the CAA’s powers as part of its aviation recovery plan to ensure passengers have a regulator that can effectively stand up for them.”

Some passengers have successfully secured refunds for vouchers they claim they didn’t ask for by going through their airline’s ADR scheme.

The CAA recommends anyone who had a voucher forced upon them, or whose airline is refusing to refund them should do the same – BA uses CEDR, while EasyJet uses CDRL.

Passengers whose airline isn’t a member of an ADR scheme should seek redress through the CAA’s Passenger Advice and Complaints team.

Kim Norris received a cash refund of £1,099 after taking her case of an unwanted voucher to BA’s alternative dispute resolution service, CEDR. It said that, on the balance of probabilities, she had not agreed to accept a voucher.

BA said that Kim applied for a voucher via its website, but it only provided CEDR a screenshot of the type of form it says she filled out, not her specific form. BA acknowledged that Kim had asked twice for a refund, by phone and by email. CEDR found that when BA issued the voucher, it was unlikely that Kim had voluntarily consented to accept it.

In its ruling, CEDR also pointed to a recommendation from the European Commission that if vouchers haven’t been redeemed by the end of their validity period they should be automatically reimbursed within 14 days.

A British Airways spokesperson said: “We do not auto-issue vouchers, they can only be issued when a customer has requested them by filling out the form. Our website is clear that when filling out the form it is to apply for vouchers.

“Customers are always entitled to a cash refund if their flight has been cancelled, and must call us to do this, which is clearly displayed on our website. Customers have up to a year after their flight was due to operate to get in touch with us for a cash refund – and we have processed over 2.1 million cash refunds to date.

“If a customer uses a voucher to make a new booking which is then subsequently cancelled by us, they would be entitled to choose either a cash refund (if the original booking was paid for in cash), or a voucher in a similar way as before.”

COVID VACCINE BREAKTHROUGH

Today is a great day for science and humanity’

The first effective vaccine against coronavirus vaccine can prevent more than 90% of people from getting Covid-19, a preliminary analysis shows. The vaccine developers, Pfizer and BioNTech – have described it as a “great day for science and humanity”.

  • Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis
  • Analysis evaluated 94 confirmed cases of COVID-19 in trial participants
  • Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected
  • Submission for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) planned for soon after the required safety milestone is achieved, which is currently expected to occur in the third week of November
  • Clinical trial to continue through to final analysis at 164 confirmed cases in order to collect further data and characterize the vaccine candidate’s performance against other study endpoints

Pfizer Inc. and BioNTech SE today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study.


“Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,” said Dr. Albert Bourla, Pfizer Chairman and CEO.

“We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen.

“With today’s news, we are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis. We look forward to sharing additional efficacy and safety data generated from thousands of participants in the coming weeks.”

After discussion with the FDA, the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases. Upon the conclusion of those discussions, the evaluable case count reached 94 and the DMC performed its first analysis on all cases.

The case split between vaccinated individuals and those who received the placebo indicates a vaccine efficacy rate above 90%, at 7 days after the second dose. This means that protection is achieved 28 days after the initiation of the vaccination, which consists of a 2-dose schedule.

As the study continues, the final vaccine efficacy percentage may vary. The DMC has not reported any serious safety concerns and recommends that the study continue to collect additional safety and efficacy data as planned. The data will be discussed with regulatory authorities worldwide.

“I want to thank the thousands of people who volunteered to participate in the clinical trial, our academic collaborators and investigators at the study sites, and our colleagues and collaborators around the world who are dedicating their time to this crucial endeavor,” added Bourla. “We could not have come this far without the tremendous commitment of everyone involved.”

“The first interim analysis of our global Phase 3 study provides evidence that a vaccine may effectively prevent COVID-19. This is a victory for innovation, science and a global collaborative effort,” said Prof. Ugur Sahin, BioNTech co-founder and CEO.

“When we embarked on this journey 10 months ago this is what we aspired to achieve. Especially today, while we are all in the midst of a second wave and many of us in lockdown, we appreciate even more how important this milestone is on our path towards ending this pandemic and for all of us to regain a sense of normality.

“We will continue to collect further data as the trial continues to enroll for a final analysis planned when a total of 164 confirmed COVID-19 cases have accrued. I would like to thank everyone who has contributed to make this important achievement possible.”

The Phase 3 clinical trial of BNT162b2 began on July 27 and has enrolled 43,538 participants to date, 38,955 of whom have received a second dose of the vaccine candidate as of November 8, 2020.

Approximately 42% of global participants and 30% of U.S. participants have racially and ethnically diverse backgrounds. The trial is continuing to enroll and is expected to continue through the final analysis when a total of 164 confirmed COVID-19 cases have accrued.

The study also will evaluate the potential for the vaccine candidate to provide protection against COVID-19 in those who have had prior exposure to SARS-CoV-2, as well as vaccine prevention against severe COVID-19 disease.

In addition to the primary efficacy endpoints evaluating confirmed COVID-19 cases accruing from 7 days after the second dose, the final analysis now will include, with the approval of the FDA, new secondary endpoints evaluating efficacy based on cases accruing 14 days after the second dose as well.

The companies believe that the addition of these secondary endpoints will help align data across all COVID-19 vaccine studies and allow for cross-trial learnings and comparisons between these novel vaccine platforms. The companies have posted an updated version of the study protocol at https://www.pfizer.com/science/coronavirus.

Pfizer and BioNTech are continuing to accumulate safety data and currently estimate that a median of two months of safety data following the second (and final) dose of the vaccine candidate – the amount of safety data specified by the FDA in its guidance for potential Emergency Use Authorization – will be available by the third week of November. Additionally, participants will continue to be monitored for long-term protection and safety for an additional two years after their second dose.

Along with the efficacy data generated from the clinical trial, Pfizer and BioNTech are working to prepare the necessary safety and manufacturing data to submit to the FDA to demonstrate the safety and quality of the vaccine product produced.

Based on current projections the companies expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021.

Pfizer and BioNTech now plan to submit data from the full Phase 3 trial for scientific peer-review publication.

Prime Minister Boris Johnson is to hold a press conference at 5pm and Scotland’s First Minister Nicola Sturgeon says the vaccine announcement is welcome news.

The First Minister ended today’s lunchtime media briefing by saying: “It might not be all that visible at the moment but there is light at the end of this tunnel.

The news we’ve heard this morning – that early indications show a vaccine being developed by the pharmaceutical company Pfizer, which has been trialled in other countries across the world, is 90% effective – is good news.  Perhaps amongst the best news we have had in recent weeks. 

“It’s not going to provide us with the way out of this today, or tomorrow, or next week, or perhaps not even in this calendar year. But this development, along with all of the work that is going into the development of other vaccines, does give us real hope that in the not too distant future, science is going to find us the way out of this terrible time. 

“So hold onto that hope today, and also use it as a motivation. What we are living through right now, and all the restrictions that are so difficult for all of us, will not last forever. But it is really important we stick with them so that we get out of the other side of this with as few people as possible becoming ill, with as few people as possible losing their lives.

“That means all of us sticking with these tough restrictions that we are all fed up with but which we know will reduce the impact of this virus. 

“So please stick with it for now and keep hold of the hope we have today that there is an end, and that we will see it in the not too distant future.” 

Real Living Wage increases to £9.50 per hour

Over 250,000 people working for almost 7,000 real Living Wage Employers throughout the country are set for a vital pay boost as the new Living Wage rates rise to £9.50 across the UK (20p increase), and £10.85 in London (10p increase), supporting workers and families through the pandemic. 

The Living Wage rates are the only rates independently calculated based on what people need to live on. 

Over 800 more employers have accredited with the Living Wage Foundation since the start of the pandemic, with major new names including Tate and Lyle Sugars, Network Railthe All England Lawn Tennis Club (The Championships, Wimbledon) and Capital One.  

These organisations join a network of almost 7,000 employers across the UK, including two-fifths of the FTSE 100 companies, household names including AvivaNationwideEverton FC, and Brewdog, as well as thousands of small businesses, who are choosing to pay the real Living Wage to ensure all staff earn a wage that meets the real cost of living, and covers everyday needs.   

Research conducted by Cardiff Business School has demonstrated the significant impact of the Living Wage campaign since the start of the pandemic.

Over 250,000 workers have benefitted from an additional £200 million since the start of lockdown, including 130,000 key workers. Since 2011 over £1.3bn in extra wages has gone to workers and families through the Living Wage.  

The UK rate is 78p per hour more than the government minimum wage (for over 25s) and the London Living Wage is £2.13 per hour higher. 

A full-time worker paid the new £9.50 real Living Wage will receive over £1,500 in additional wages annually compared to the current Government minimum. For a full-time worker in London this figure rises to over £4,000.
 
The announcement comes as new research by the Living Wage Foundation has demonstrated the scale of low pay during the pandemic, with 5.5 milion jobs (20.3% of employee jobs) still paying less than the real Living Wage. 

Northern Ireland had the highest proportion of jobs paying below the Living Wage (25.3%) and Scotland the lowest (15.2%). 


 Laura Gardiner, Living Wage Foundation Director, said: “It’s an incredibly challenging time for us all, but today’s new Living Wage rates will give a boost to hundreds of thousands of UK workers, including thousands of key and essential workers like cleaners, care workers, and delivery drivers who have kept our economy going.  

“Since the start of the pandemic employers have continued to sign up to a real Living Wage. During Living Wage Week it’s right that we celebrate those employers that have done right by workers and families, providing them with much needed security and stability even when times are hard. These are the employers that will allow us to recover and rebuild from this crisis.”  

The Archbishop of York, the Most Revd Stephen Cottrell, said: “As our leaders continue to grapple with managing this pandemic, it is critical that all of our workers are kept in the heart of all quarantine management and recovery plans.

“Throughout this pandemic, we have depended on those of us who have selflessly put their work ahead of their own health and wellbeing for the continued functioning of our society.

“Over the past few months, we have recognised and applauded their fantastic work; now, this Living Wage Week, it is time we do the morally right thing and follow this recognition with well-deserved reward, paying them what they need to live. It is right to be paid a fair day’s wage.” 

Gerald Mason, Senior Vice President of Tate and Lyle Sugars, said“Tate & Lyle Sugars is proud to have been formally accredited as a Living Wage employer.

“It has been the cleaners, security guards and catering staff who have kept our factories clean, safe and well-fed over the last 6 difficult months. We’re pleased to recognise their value and role in helping us feed the nation.” 

Loraine Martins, Network Rail’s Director of Diversity and Inclusion, said: “I am delighted that Network Rail has been accredited as a Real Living Wage employer. While we already pay our 41,000 employees the Real Living Wage, official accreditation by the Living Wage Foundation means that thousands of rail workers in our supply chain will also benefit. 

“The varied work that rail staff carry out on our trains, in our stations and on our tracks has never been more important than in recent months, where they have helped to keep Britain connected in challenging times by running a safe and reliable service for key workers and others relying on the railway.

“Our work with contractors and the Living Wage Foundation will ensure that railway staff are paid appropriately for their vital work.” 

Owen, Team Member of TTK Confectionary Nottingham, said: “The Real Living Wage has allowed me to pay my bills and save for the first time.

“I am saving for driving lessons and a car. I feel valued and appreciated and that my hard work and dedication has been recognised through the introduction of the Living Wage.” 

Oliver, a delivery rider at e-cargobikes.com, said: Earning a Living Wage means I am able to support a household, including my partner, and takes a huge load from my shoulders.

“To be employed by an organisation that not only treats people with respect but backs that up with decent pay means that I feel valued in a way that no other flexible work has provided.

“The psychological benefit of this will extend further than me and reminds me that I work for a company that sees further than the person as an employee, but also sees their capacity to contribute to wider society when treated fairly.”